BIOLOGICAL · Unmapped registry intervention
tocilizumab
Find medicine records ·
Find other trials using this name
Clinical trial
Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
NCT00868751
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSingle Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Arthritis, Juvenile Rheumatoidunresolved
Still's Disease, Juvenile Onsetunresolved
Interventions
tocilizumabBIOLOGICAL
Sponsors & collaborators
Tufts Medical Centerlead sponsor
Hoffmann-La Rochecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00868751 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.